V. Schuermans
Impact in
- Small Animals top 5%
- Helminth infection and control
- Infectious Diseases and Mycology
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 3
- Amoebic Infections and Treatments 1
-
- Pharmaceutical studies and practices 3
- Co-authors
- J Brugmans (7 shared papers)D. Thienpont (3 shared papers)H. Verhaegen (3 shared papers)W. De Cock (3 shared papers)Piet De Doncker (1 shared paper)Harry Goyvaerts (2 shared papers)J. Heykants (1 shared paper)G. Cauwenbergh (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)The Lancet (2 papers)European Journal of Clinical Pharmacology (1 paper)Drug Information Journal (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- Belgium
In The Last Decade
V. Schuermans
13 papers receiving 446 citations
Peers
Comparison fields: 5 of 92
- Small Animals 85
- Infectious Diseases 165
- Epidemiology 178
- Parasitology 36
- Pharmacology 46
Countries citing papers authored by V. Schuermans
This map shows the geographic impact of V. Schuermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Schuermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Schuermans more than expected).
Fields of papers citing papers by V. Schuermans
This network shows the impact of papers produced by V. Schuermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Schuermans. The network helps show where V. Schuermans may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Schuermans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 114 | |
| 2 | Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects. | 1971 | 85 |
| 3 | 1987 | 81 | |
| 4 | 1972 | 71 | |
| 5 | 1973 | 56 | |
| 6 | 1974 | 37 | |
| 7 | 1974 | 32 | |
| 8 | 1972 | 18 | |
| 9 | 1973 | 18 | |
| 10 | 1986 | 17 | |
| 11 | 1978 | 9 | |
| 12 | 1987 | 2 | |
| 13 | 1993 | 2 |
About V. Schuermans
V. Schuermans is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health, Epidemiology, Surgery and Pharmacology, having authored 13 papers that have together received 542 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (3 papers), Nail Diseases and Treatments (3 papers), Pharmaceutical studies and practices (3 papers), Parasites and Host Interactions (2 papers), Epilepsy research and treatment (2 papers), Fungal Infections and Studies (2 papers), Allergic Rhinitis and Sensitization (1 paper) and Amoebic Infections and Treatments (1 paper). The work is most often cited by research in Small Animals (85 citations), Infectious Diseases (165 citations), Epidemiology (178 citations), Parasitology (36 citations) and Pharmacology (46 citations). V. Schuermans has collaborated with scholars based in Belgium. Frequent co-authors include J Brugmans, D. Thienpont, H. Verhaegen, W. De Cock, Piet De Doncker, Harry Goyvaerts, J. Heykants, G. Cauwenbergh, O. Vanparijs and J. Van Cutsem. Their work appears in journals such as Clinical Infectious Diseases, The Lancet, European Journal of Clinical Pharmacology, Drug Information Journal and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.